1,000+ M&A transactions for an aggregate value of $555+ billion since 2020
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Learn More
Cooley Continues Climb in US and Global M&A and Private Equity Rankings
Learn More
Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million
Learn More
Angion and Elicio Therapeutics Enter Into Definitive Merger Agreement
Learn More
Inscripta Acquires Infinome Biosciences and Sestina Bio
Learn More
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
Learn More
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction
Learn More
Ritchie Bros. to Acquire IAA in $7.3 Billion Cross-Border Stock and Cash Transaction
Learn More
Cooley Adds M&A and Private Equity Partner to Growing Shanghai Office
Learn More
Why Cooley
- 180+ member team in 18 major business and technology centers in the US, Europe and Asia
- Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
- Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
- Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
- Primary corporate counsel to 240+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
- Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others
- Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
- Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity
- Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions
M&A Blog
Newsworthy developments in the global mergers and acquisitions space
View blog
Recognition
- Chambers: Ranked for USA - Nationwide Corporate/M&A (2022)
- Bloomberg: Top 2 for Global, US and UK M&A by Deal Count (2022)
- Bloomberg: #1 for Global and US Mid-market M&A (2022)
- Mergermarket: Top 5 for Global M&A by Deal Count (2022)
- Mergermarket: Top 3 for US M&A by Deal Count (2022)
- Refinitiv: Top 6 for Global M&A by Deal Count (2022)
- Refinitiv: Top 4 for US M&A by Deal Count (2022)
Public Company Innovation Hub
Resources for forward-thinking board members and leaders of US-listed public companies
Visit hub
Global Business Hub
Resources for US companies to launch and succeed in new global markets
Visit hub
Group contacts
Anne Lieberman
Partner
Los Angeles – Santa Monica, Los Angeles – Downtown
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.